These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23201222)

  • 1. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
    Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
    Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.
    Jullien N; Maudinet A; Leloutre B; Ringe J; Häupl T; Marie PJ
    J Cell Biochem; 2012 Jun; 113(6):2047-56. PubMed ID: 22274864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.
    He X; Wang H; Jin T; Xu Y; Mei L; Yang J
    PLoS One; 2016; 11(3):e0149876. PubMed ID: 26930594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
    Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging.
    Haÿ E; Dieudonné FX; Saidak Z; Marty C; Brun J; Da Nascimento S; Sonnet P; Marie PJ
    J Cell Physiol; 2014 Nov; 229(11):1765-75. PubMed ID: 24664975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
    Govoni KE; Baylink DJ; Chen J; Mohan S
    Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.
    Saidak Z; Haÿ E; Marty C; Barbara A; Marie PJ
    Aging Cell; 2012 Jun; 11(3):467-74. PubMed ID: 22321691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells.
    Briolay A; Lencel P; Bessueille L; Caverzasio J; Buchet R; Magne D
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1072-7. PubMed ID: 23266365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate-enhanced Wnt5a promotes osteogenic differentiation in C3H10T1/2 cells.
    Hashimoto Y; Kobayashi M; Matsuzaki E; Higashi K; Takahashi-Yanaga F; Takano A; Hirata M; Nishimura F
    Cell Biol Int; 2016 Oct; 40(10):1129-36. PubMed ID: 27486054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5A induces osteogenic differentiation of human adipose stem cells via rho-associated kinase ROCK.
    Santos A; Bakker AD; de Blieck-Hogervorst JM; Klein-Nulend J
    Cytotherapy; 2010 Nov; 12(7):924-32. PubMed ID: 20429785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt5a attenuates Wnt3a-induced alkaline phosphatase expression in dental follicle cells.
    Sakisaka Y; Tsuchiya M; Nakamura T; Tamura M; Shimauchi H; Nemoto E
    Exp Cell Res; 2015 Aug; 336(1):85-93. PubMed ID: 26112214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: implication of FGFR2 signaling.
    Miraoui H; Severe N; Vaudin P; Pagès JC; Marie PJ
    J Cell Biochem; 2010 Aug; 110(5):1147-54. PubMed ID: 20564211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y; Rubin B; Bodine PV; Billiard J
    J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of osteoblast differentiation in mesenchymal cells through Cbl-mediated control of STAT5 activity.
    Dieudonne FX; Sévère N; Biosse-Duplan M; Weng JJ; Su Y; Marie PJ
    Stem Cells; 2013 Jul; 31(7):1340-9. PubMed ID: 23533197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.